Skip to main content
Clinical Trials/NCT01751841
NCT01751841
Completed
Not Applicable

Outcome Analysis for Minimally Invasive Spine Surgery and Navigation

Weill Medical College of Cornell University1 site in 1 country200 target enrollmentMay 1, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Degenerative Disc Disease
Sponsor
Weill Medical College of Cornell University
Enrollment
200
Locations
1
Primary Endpoint
Visual analog scale (VAS)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Prospective/Retrospective data analysis, chart reviews and clinical outcomes of minimally invasive spine surgery

Detailed Description

STUDY RATIONALE AND PRIMARY OBJECTIVE/HYPOTHESIS To assess the clinical and radiographic outcome of spinal fusion procedures using Silicate-Substituted Calcium Phosphate (Si-CaP), a newer-generation of synthetic ceramics designed to maximize osteoinduction and osteoconduction. STUDY DESIGN Retrospective Study PURPOSE OF THE STUDY Providing compelling evidence for the efficacy of Si-CaP in terms of resulting in satisfactory fusion. SUMMARY OF METHODS A prospectively collected database will be reviewed retrospectively, to retrieve data of 200 patients who have undergone different spinal fusion procedures using Silicate-Substituted Calcium Phosphate (Si-CaP). An average follow up duration of at least 12 months will be considered. Clinical outcomes will be assessed using the visual analog scale (VAS), Oswestry Disability Index (ODI), and Neck Disability Index (NDI). Pre-operative scores will be compared to the latest follow-up scores. A board certified Neuro-radiologist will assess the fusion rate. Fusion will be determined by the presence of bony bridging on 2 consecutive sections in at least 2 planes on computed tomographic imaging. SECONDARY ENDPOINTS AND EXPECTED RESULTS The purpose of this study is to evaluate the level of clinical and radiographic improvement in patients implanted with Silicate-Substituted Calcium Phosphate (Si-CaP) as a bone graft substitute material for spinal fusions. More comprehensive long term studies will be able to provide compelling evidence for the efficacy of Si-CaP in terms of resulting in satisfactory fusion. They can more strongly support the previously published data implying that Si-CaP can be utilized as an alternative to autogenous bone graft in spinal arthrodesis procedures.

Registry
clinicaltrials.gov
Start Date
May 1, 2012
End Date
October 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with different spinal fusion procedures (including axial lumbar interbody fusion, transforaminal lumbar interbody fusion, extreme lateral interbody fusion, posterior cervical fusion, and anterior discectomy and fusion using Silicate-Substituted Calcium Phosphate as a bone graft substitute.

Exclusion Criteria

  • Utilization of any other bone extenders in addition to Si-CaP as a bone graft substitute.

Outcomes

Primary Outcomes

Visual analog scale (VAS)

Time Frame: Up to 2 years

Pre-operative pain scores will be compared to the latest follow-up pain scores.

Secondary Outcomes

  • Neck Disability Index (NDI)(Up to 2 years)
  • Fusion on CT imaging or flexion-extension radiographs.(Up to 2 years)
  • Oswestry Disability Index (ODI)(Up to 2 years)

Study Sites (1)

Loading locations...

Similar Trials